Replies to post #172848 on Biotech Values

[vinmantoo]

{{I'm probably stating the obvious but I believe that the more personalized we get with cancer, the better success rates we see in both drug development and treatment outcome. }}

Yes, but the market size for a drug may decline as it will only be prescribed in patient populations where the genetic profile increases chance for a positive effect.